The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Angiopoietin 2-Global Market Insights and Sales Trends 2025
Synopsis
The global Angiopoietin 2 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Angiopoietin 2 in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Angiopoietin 2 market. Atu-111, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the BI-836880 segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Angiopoietin 2, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Angiopoietin 2 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Angiopoietin 2 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Angiopoietin 2 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Angiopoietin 2 covered in this report include Amgen Inc., AnGes MG, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., MedImmune, LLC, Regeneron Pharmaceuticals, Inc., RXi Pharmaceuticals Corporation and Silence Therapeutics Plc, etc.
The global Angiopoietin 2 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
Global Angiopoietin 2 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Angiopoietin 2 market, Segment by Type:
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Global Angiopoietin 2 market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Angiopoietin 2 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Angiopoietin 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Angiopoietin 2 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Angiopoietin 2 in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Angiopoietin 2 market. Atu-111, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the BI-836880 segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Angiopoietin 2, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Angiopoietin 2 market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Angiopoietin 2 market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Angiopoietin 2 sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Angiopoietin 2 covered in this report include Amgen Inc., AnGes MG, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., MedImmune, LLC, Regeneron Pharmaceuticals, Inc., RXi Pharmaceuticals Corporation and Silence Therapeutics Plc, etc.
The global Angiopoietin 2 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
Global Angiopoietin 2 market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Angiopoietin 2 market, Segment by Type:
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Global Angiopoietin 2 market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Angiopoietin 2 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Angiopoietin 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Angiopoietin 2 Market Overview
1.1 Angiopoietin 2 Product Overview
1.2 Angiopoietin 2 Market Segment by Type
1.2.1 Atu-111
1.2.2 BI-836880
1.2.3 LY-3127804
1.2.4 MEDI-3617
1.2.5 Others
1.3 Global Angiopoietin 2 Market Size by Type
1.3.1 Global Angiopoietin 2 Market Size Overview by Type (2018-2029)
1.3.2 Global Angiopoietin 2 Historic Market Size Review by Type (2018-2023)
1.3.3 Global Angiopoietin 2 Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Angiopoietin 2 Sales Breakdown by Type (2018-2023)
1.4.2 Europe Angiopoietin 2 Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Angiopoietin 2 Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Angiopoietin 2 Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Angiopoietin 2 Sales Breakdown by Type (2018-2023)
2 Global Angiopoietin 2 Market Competition by Company
2.1 Global Top Players by Angiopoietin 2 Sales (2018-2023)
2.2 Global Top Players by Angiopoietin 2 Revenue (2018-2023)
2.3 Global Top Players by Angiopoietin 2 Price (2018-2023)
2.4 Global Top Manufacturers Angiopoietin 2 Manufacturing Base Distribution, Sales Area, Product Type
2.5 Angiopoietin 2 Market Competitive Situation and Trends
2.5.1 Angiopoietin 2 Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Angiopoietin 2 Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiopoietin 2 as of 2022)
2.7 Date of Key Manufacturers Enter into Angiopoietin 2 Market
2.8 Key Manufacturers Angiopoietin 2 Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Angiopoietin 2 Status and Outlook by Region
3.1 Global Angiopoietin 2 Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Angiopoietin 2 Historic Market Size by Region
3.2.1 Global Angiopoietin 2 Sales in Volume by Region (2018-2023)
3.2.2 Global Angiopoietin 2 Sales in Value by Region (2018-2023)
3.2.3 Global Angiopoietin 2 Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Angiopoietin 2 Forecasted Market Size by Region
3.3.1 Global Angiopoietin 2 Sales in Volume by Region (2024-2029)
3.3.2 Global Angiopoietin 2 Sales in Value by Region (2024-2029)
3.3.3 Global Angiopoietin 2 Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Angiopoietin 2 by Application
4.1 Angiopoietin 2 Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Angiopoietin 2 Market Size by Application
4.2.1 Global Angiopoietin 2 Market Size Overview by Application (2018-2029)
4.2.2 Global Angiopoietin 2 Historic Market Size Review by Application (2018-2023)
4.2.3 Global Angiopoietin 2 Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Angiopoietin 2 Sales Breakdown by Application (2018-2023)
4.3.2 Europe Angiopoietin 2 Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Angiopoietin 2 Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Angiopoietin 2 Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Angiopoietin 2 Sales Breakdown by Application (2018-2023)
5 North America Angiopoietin 2 by Country
5.1 North America Angiopoietin 2 Historic Market Size by Country
5.1.1 North America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Angiopoietin 2 Sales in Volume by Country (2018-2023)
5.1.3 North America Angiopoietin 2 Sales in Value by Country (2018-2023)
5.2 North America Angiopoietin 2 Forecasted Market Size by Country
5.2.1 North America Angiopoietin 2 Sales in Volume by Country (2024-2029)
5.2.2 North America Angiopoietin 2 Sales in Value by Country (2024-2029)
6 Europe Angiopoietin 2 by Country
6.1 Europe Angiopoietin 2 Historic Market Size by Country
6.1.1 Europe Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Angiopoietin 2 Sales in Volume by Country (2018-2023)
6.1.3 Europe Angiopoietin 2 Sales in Value by Country (2018-2023)
6.2 Europe Angiopoietin 2 Forecasted Market Size by Country
6.2.1 Europe Angiopoietin 2 Sales in Volume by Country (2024-2029)
6.2.2 Europe Angiopoietin 2 Sales in Value by Country (2024-2029)
7 Asia-Pacific Angiopoietin 2 by Region
7.1 Asia-Pacific Angiopoietin 2 Historic Market Size by Region
7.1.1 Asia-Pacific Angiopoietin 2 Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Angiopoietin 2 Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Angiopoietin 2 Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Angiopoietin 2 Forecasted Market Size by Region
7.2.1 Asia-Pacific Angiopoietin 2 Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Angiopoietin 2 Sales in Value by Region (2024-2029)
8 Latin America Angiopoietin 2 by Country
8.1 Latin America Angiopoietin 2 Historic Market Size by Country
8.1.1 Latin America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Angiopoietin 2 Sales in Volume by Country (2018-2023)
8.1.3 Latin America Angiopoietin 2 Sales in Value by Country (2018-2023)
8.2 Latin America Angiopoietin 2 Forecasted Market Size by Country
8.2.1 Latin America Angiopoietin 2 Sales in Volume by Country (2024-2029)
8.2.2 Latin America Angiopoietin 2 Sales in Value by Country (2024-2029)
9 Middle East and Africa Angiopoietin 2 by Country
9.1 Middle East and Africa Angiopoietin 2 Historic Market Size by Country
9.1.1 Middle East and Africa Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Angiopoietin 2 Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Angiopoietin 2 Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Angiopoietin 2 Forecasted Market Size by Country
9.2.1 Middle East and Africa Angiopoietin 2 Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Angiopoietin 2 Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Amgen Inc.
10.1.1 Amgen Inc. Company Information
10.1.2 Amgen Inc. Introduction and Business Overview
10.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Amgen Inc. Angiopoietin 2 Products Offered
10.1.5 Amgen Inc. Recent Development
10.2 AnGes MG, Inc.
10.2.1 AnGes MG, Inc. Company Information
10.2.2 AnGes MG, Inc. Introduction and Business Overview
10.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AnGes MG, Inc. Angiopoietin 2 Products Offered
10.2.5 AnGes MG, Inc. Recent Development
10.3 Boehringer Ingelheim GmbH
10.3.1 Boehringer Ingelheim GmbH Company Information
10.3.2 Boehringer Ingelheim GmbH Introduction and Business Overview
10.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Products Offered
10.3.5 Boehringer Ingelheim GmbH Recent Development
10.4 Eli Lilly and Company
10.4.1 Eli Lilly and Company Company Information
10.4.2 Eli Lilly and Company Introduction and Business Overview
10.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lilly and Company Angiopoietin 2 Products Offered
10.4.5 Eli Lilly and Company Recent Development
10.5 F. Hoffmann-La Roche Ltd.
10.5.1 F. Hoffmann-La Roche Ltd. Company Information
10.5.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Products Offered
10.5.5 F. Hoffmann-La Roche Ltd. Recent Development
10.6 MedImmune, LLC
10.6.1 MedImmune, LLC Company Information
10.6.2 MedImmune, LLC Introduction and Business Overview
10.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.6.4 MedImmune, LLC Angiopoietin 2 Products Offered
10.6.5 MedImmune, LLC Recent Development
10.7 Regeneron Pharmaceuticals, Inc.
10.7.1 Regeneron Pharmaceuticals, Inc. Company Information
10.7.2 Regeneron Pharmaceuticals, Inc. Introduction and Business Overview
10.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Products Offered
10.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
10.8 RXi Pharmaceuticals Corporation
10.8.1 RXi Pharmaceuticals Corporation Company Information
10.8.2 RXi Pharmaceuticals Corporation Introduction and Business Overview
10.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Products Offered
10.8.5 RXi Pharmaceuticals Corporation Recent Development
10.9 Silence Therapeutics Plc
10.9.1 Silence Therapeutics Plc Company Information
10.9.2 Silence Therapeutics Plc Introduction and Business Overview
10.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Silence Therapeutics Plc Angiopoietin 2 Products Offered
10.9.5 Silence Therapeutics Plc Recent Development
10.10 Synergys Biotherapeutics, Inc.
10.10.1 Synergys Biotherapeutics, Inc. Company Information
10.10.2 Synergys Biotherapeutics, Inc. Introduction and Business Overview
10.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Products Offered
10.10.5 Synergys Biotherapeutics, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Angiopoietin 2 Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Angiopoietin 2 Industrial Chain Analysis
11.4 Angiopoietin 2 Market Dynamics
11.4.1 Angiopoietin 2 Industry Trends
11.4.2 Angiopoietin 2 Market Drivers
11.4.3 Angiopoietin 2 Market Challenges
11.4.4 Angiopoietin 2 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Angiopoietin 2 Distributors
12.3 Angiopoietin 2 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
